Does transaction misalignment matter for firm survival at all stages of the industry life cycle?

被引:60
|
作者
Argyres, Nicholas [1 ]
Bigelow, Lyda
机构
[1] Boston Univ, Sch Management, Boston, MA 02215 USA
[2] Univ Utah, David Eccles Sch Business, Salt Lake City, UT 84112 USA
关键词
industry life cycle; transaction costs; dominant design manufacturing; strategy;
D O I
10.1287/mnsc.1070.0706
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
Research on industry life cycles suggests that competitive pressures are more severe during the shakeout stage, which could be associated with the emergence of a dominant design, than at other stages. Transaction-cost theory, on the other hand, assumes generally competitive markets and does not address the industry life cycle. It therefore implies that transaction-cost economizing is a superior firm strategy regardless of the stage of the life cycle. This paper seeks to reconcile these two streams of research by investigating whether aligning transactions with governance modes in accordance with transaction-cost prescriptions has a differential effect on firm survival in preshakeout versus shakeout stages of the industry life cycle. Analyzing data from the early U.S. auto industry (1917-1933), we find that while transaction misalignment did not have a significant impact on firm survival during the preshakeout stage or during the period as a whole, it did have a significantly larger negative impact on survival during the shakeout stage than during the preshakeout stage. We also find that the negative effects of misalignment on survival were significantly weaker for larger firms during the shakeout stage. This suggests that applications of transaction-cost theory which assume uniformly severe selection pressures across the industry life cycle and uniform effects of misalignment across firms of different sizes could be misleading. It also suggests that theories of the industry life cycle could usefully take transaction costs into account along with production costs in their analyses of competition over the life cycle.
引用
收藏
页码:1332 / 1344
页数:13
相关论文
共 50 条
  • [41] Method of assurance of reliability of complex products at all stages of life cycle
    Trukhanov, V.M.
    Problemy Mashinostraeniya i Nadezhnos'ti Mashin, 2002, (06): : 25 - 29
  • [42] CLASSIFICATION OF COMPANY LIFE CYCLE STAGES: AN AUTOMOTIVE INDUSTRY IN THE CZECH REPUBLIC
    Slavickova, Jana
    Slavicek, Ondrej
    E & M EKONOMIE A MANAGEMENT, 2022, 25 (04): : 85 - 99
  • [43] Parent firm performance across international joint venture life-cycle stages
    Reuer, JJ
    JOURNAL OF INTERNATIONAL BUSINESS STUDIES, 2000, 31 (01) : 1 - 20
  • [44] Parent Firm Performance across International Joint Venture Life-cycle Stages
    Jeffrey J. Reuer
    Journal of International Business Studies, 2000, 31 : 1 - 20
  • [45] The Relationship Between Gender and Promotion Over the Business Cycle: Does Firm Size Matter?
    Saridakis, George
    Ferreira, Priscila
    Mohammed, Anne-Marie
    Marlow, Susan
    BRITISH JOURNAL OF MANAGEMENT, 2022, 33 (02) : 806 - 827
  • [46] Board Gender Diversity and Cost of Debt: Does Firm Size and Industry type matter?
    Kamil, Rabiatu
    Appiah, Kingsley Opoku
    GENDER IN MANAGEMENT, 2022, 37 (01): : 19 - 38
  • [47] Technical efficiency and technology gap of the manufacturing industry in China: Does firm ownership matter?
    Walheer, Barnabe
    He, Ming
    WORLD DEVELOPMENT, 2020, 127
  • [48] Does firm life cycle have impacts on managerial promotion tournament incentives?
    Chowdhury, Hasibul
    Shams, Syed
    AUSTRALIAN JOURNAL OF MANAGEMENT, 2021, 46 (04) : 593 - 628
  • [49] REDISCOVERY OF DICTYA DISJUNCTA ORTH (DIPTERA: SCIOMYZIDAE) WITH DESCRIPTIONS OF ALL LIFE STAGES AND LIFE CYCLE
    Murphy, William L.
    PROCEEDINGS OF THE ENTOMOLOGICAL SOCIETY OF WASHINGTON, 2014, 116 (02) : 172 - 187
  • [50] Small-Molecule Xenomycins Inhibit All Stages of the Plasmodium Life Cycle
    Erath, Jessey
    Gallego-Delgado, Julio
    Xu, Wenyue
    Andriani, Grasiella
    Tanghe, Scott
    Gurova, Katerina V.
    Gudkov, Andrei
    Purmal, Andrei
    Rydkina, Elena
    Rodriguez, Ana
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (03) : 1427 - 1434